Bvf Inc Spero Therapeutics, Inc. Transaction History

Bvf Inc

  • $3.15 Billion
  • Q3 2024

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.68 - $2.2 $788,962 - $2.55 Million
-1,160,239 Reduced 37.55%
1,929,376 $3.86 Million
Q2 2022

Aug 15, 2022
BUY
$0.74 - $7.44 $1.11 Million - $11.2 Million
1,504,000 Added 94.85%
3,089,615 $2.29 Million
Q4 2021

Feb 14, 2022
SELL
$13.09 - $18.77 $2.93 Million - $4.2 Million
-223,737 Reduced 12.37%
1,585,615 $25.4 Million
Q3 2021

Nov 15, 2021
SELL
$13.03 - $19.51 $4.28 Million - $6.41 Million
-328,626 Reduced 15.37%
1,809,352 $33.3 Million
Q1 2021

May 17, 2021
SELL
$13.23 - $21.48 $1.39 Million - $2.26 Million
-105,300 Reduced 4.69%
2,137,978 $31.5 Million
Q4 2020

Feb 12, 2021
BUY
$11.65 - $22.07 $10.5 Million - $19.8 Million
898,944 Added 66.87%
2,243,278 $43.5 Million
Q3 2020

Nov 13, 2020
BUY
$8.96 - $14.12 $7.69 Million - $12.1 Million
857,794 Added 176.3%
1,344,334 $15 Million
Q2 2020

Aug 14, 2020
SELL
$7.27 - $14.18 $558,721 - $1.09 Million
-76,853 Reduced 13.64%
486,540 $6.58 Million
Q1 2020

May 15, 2020
SELL
$5.27 - $10.41 $1.49 Million - $2.94 Million
-282,012 Reduced 33.36%
563,393 $4.55 Million
Q4 2019

Feb 14, 2020
SELL
$9.46 - $12.16 $892,068 - $1.15 Million
-94,299 Reduced 10.03%
845,405 $8.13 Million
Q2 2019

Aug 14, 2019
BUY
$10.25 - $14.36 $4.91 Million - $6.88 Million
478,998 Added 103.97%
939,704 $10.8 Million
Q1 2019

May 15, 2019
SELL
$6.26 - $13.31 $2.39 Million - $5.09 Million
-382,440 Reduced 45.36%
460,706 $5.9 Million
Q4 2018

Feb 14, 2019
SELL
$5.69 - $11.28 $3.67 Million - $7.27 Million
-644,942 Reduced 43.34%
843,146 $5.19 Million
Q3 2018

Nov 14, 2018
BUY
$9.69 - $17.79 $4.26 Million - $7.81 Million
439,130 Added 41.86%
1,488,088 $15.6 Million
Q1 2018

May 07, 2018
BUY
$9.96 - $14.61 $196,939 - $288,883
19,773 Added 1.92%
1,048,958 $14.9 Million
Q4 2017

Feb 14, 2018
BUY
$10.43 - $14.75 $10.7 Million - $15.2 Million
1,029,185
1,029,185 $12.1 Million

Others Institutions Holding SPRO

# of Institutions
49
Shares Held
13.9M
Call Options Held
200
Put Options Held
200
View Full List

About Spero Therapeutics, Inc.

SPRO Quotes by TradingView
  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $33.3M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email